Ceryvyn Therapeutics Limited
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $48.4M | $172.5M | $89.2M | $44.6M | $118.2M | $42.7M | $15.1M |
| Accounts Receivable | $419.0K | $1.4M | $636.6K | $257.7K | $565.3K | $195.6K | $207.7K |
| Inventory | — | — | — | — | — | — | — |
| Total Current Assets | $56.8M | $188.2M | $98.4M | $59.9M | $138.1M | $49.0M | $25.9M |
| Property, Plant & Equipment | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — |
| Total Assets | $56.8M | $188.8M | $98.6M | $60.0M | $138.4M | $49.4M | $26.4M |
| Liabilities | |||||||
| Accounts Payable | $9.7M | $38.1M | $17.9M | $11.4M | $2.5M | $4.1M | $4.2M |
| Total Current Liabilities | $257.9M | $64.1M | $18.7M | $12.0M | $3.1M | $4.8M | $4.6M |
| Long-Term Debt | — | — | — | — | — | — | — |
| Total Liabilities | $257.9M | $264.6M | $104.5M | $12.1M | $3.1M | $4.9M | $4.6M |
| Stockholders' Equity | |||||||
| Retained Earnings | $-742.5M | $-579.7M | $-359.5M | $-216.9M | $-124.1M | $-78.8M | $-67.7M |
| Total Stockholders' Equity | $-201.1M | $-75.8M | $-5.9M | $48.0M | $135.3M | $44.6M | $21.9M |